Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Gergen Mark J
Relationship:  
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   657,039    

Indirect Shares

   0      
Direct Value   $2,017,738    

Indirect Value

   $0      
Total Shares   657,039      
Total Value   $2,017,738      


Mirati Therapeutics, Inc. $337,408 Poseida Therapeutics, Inc. $1,680,331 Mirati Therapeutics, Inc. $337,408 Poseida Therapeutics, Inc. $1,680,331
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amylin Pharmaceuticals Inc AMLN SVP, Corporate Develop... 2012-08-08 0 2012-08-08 0    Premium*  
            Mirati Therapeutics, Inc. MRTX Executive VP, COO 2016-01-15 5,748 2016-01-15 0    Premium*  
            Poseida Therapeutics, Inc. PSTX 2024-03-01 651,291 2022-02-01 0    Premium*  
* Premium Members only  

Records found :    59         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-06-01 4 OE $16.80 $16,800 D/D 1,000 3,937 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-07-02 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-07-24 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-08-01 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-08-07 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-09-04 4 OE $16.80 $16,800 D/D 1,000 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-10-01 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-10-03 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-11-01 4 OE $16.80 $8,400 D/D 500 3,437 0 -
AMLN Amylin Pharmaceuticals In... SVP, Corporate DevelopmentSVP,   •       –      –    2012-03-01 4 S $17.11 $31,585 D/D (1,846) 53,814 0 -
AMLN Amylin Pharmaceuticals In... SVP Corporate Development   •       –      –    2010-02-03 4 A $17.83 $7,346 D/D 412 6,079 0 -
MRTX Mirati Therapeutics, Inc. Executive VP, COO   •       –      –    2016-01-15 4 S $25.92 $259,211 D/D (10,000) 5,748 0 -
AMLN Amylin Pharmaceuticals In... SVP, Corporate DevelopmentSVP,   •       –      –    2012-08-08 4 D $31.00 $2,007,256 D/D (64,750) 0 0 -
AMLN Amylin Pharmaceuticals In... SVP, Corporate DevelopmentSVP,   •       –      –    2012-08-08 4 A $31.00 $1,648,611 D/D 53,181 53,181 0 -
AMLN Amylin Pharmaceuticals In... SVP, Corporate DevelopmentSVP,   •       –      –    2012-08-08 4 D $31.00 $1,648,611 D/D (53,181) 0 0 -
AMLN Amylin Pharmaceuticals In... SVP, Corporate DevelopmentSVP,   •       –      –    2012-08-08 4 D $31.00 $328,085 I/I (10,583) 0 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-02-28 4 A $33.07 $11,245 D/D 340 2,937 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-01-31 4 A $36.07 $15,005 D/D 416 2,597 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-01-03 4 AS $36.29 $18,145 D/D (500) 2,181 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2008-02-01 4 A $37.00 $6,734 D/D 182 3,069 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-04-02 4 AS $37.47 $18,735 D/D (500) 2,937 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-03-01 4 AS $37.75 $18,875 D/D (500) 2,937 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-02-01 4 AS $38.75 $19,375 D/D (500) 2,597 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-07-02 4 AS $41.20 $20,600 D/D (500) 2,937 0 -
AMLN Amylin Pharmaceuticals In... Sr VP, Corporate Development   •       –      –    2007-05-01 4 AS $41.25 $20,625 D/D (500) 2,937 0 -
  59  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us